Astal Laboratories share news, announcements and annual reports
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹63.07.
30 Oct: open ₹63.95, high ₹64.00, low ₹60.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹270 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 0.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 12,192
Astal Laboratories share news and announcements
547 announcements, routine notices left out, newest first. Page 5 of 11.
Aug 2023
11 Aug · Board meeting
Meeting on 18 Aug 2023: preferential issue of shares, annual general meeting and increase in authorised capital10 Aug · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Jul 2023
15 Jul · Management
15 Jul · Management
15 Jul · Management
15 Jul · Management
15 Jul · Results
10 Jul · Board meeting
Meeting on 15 Jul 2023: quarterly results
Jun 2023
9 Jun · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
May 2023
27 May · Disclosure Of Related Party Transactions For The Half Year Ended On March 31, 2023.
23 May · Board meeting
Meeting on 27 May 2023: audited results
Apr 2023
28 Apr · Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
21 Apr · Compliance Certificate In Term Of Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
19 Apr · Board meeting
Meeting on 19 Apr 2023
Feb 2023
7 Feb · Board meeting
Meeting on 14 Feb 2023: quarterly results
Jan 2023
20 Jan · Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
19 Jan · Meeting
Dec 2022
27 Dec · Re-Constitution Of Committees Of The Company